RxDoctor Payments Data

Alejandra Castillo-Roth, MD

Gastroenterology · Santa Fe, NMNPI 1124222401

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.2% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,599, more than ten times the $108 reported in 2021.

$3,751in general payments, 2019–2025

Across 139 payments — averaging $26.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$710
  • Johnson & Johnson$705
  • Boston Scientific$668
  • Medtronic$333
  • Takeda Pharmaceuticals U.S.A., Inc.$260
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$169
  • plus $907 from 17 others

What the payments were for

  • Food & beverage$3,49493%
  • Education$2577%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,751 in reported general payments places this provider in the 75th percentile of 81 gastroenterology providers in New Mexico.

See all gastroenterology providers in New Mexico

Medicare billing

Part B allowed, 2024
$184,247
Medicare patients
675
Services billed
1,171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg481$11,161
Sucralfate23$5,225
Ursodiol11$1,950
Omeprazole203$1,943
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl100$1,896
CholestyramineCholestyramine (With Sugar)12$1,228
Pantoprazole Sodium39$936
Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg23$454
Famotidine23$363
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl12$193
Propranolol Hcl12$39

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Santa Fe

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →